STOCK TITAN

SeaSpine to Present at the Canaccord Genuity 42nd Annual Global Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

SeaSpine Holdings Corporation (NASDAQ: SPNE) announced its participation in the Canaccord Genuity 42nd Annual Global Growth Conference scheduled for August 10, 2022, starting at 8:00 AM ET. The event aims to showcase the company's innovative surgical solutions for spinal disorders, including its FLASH™ Navigation system, which enhances surgical accuracy. A live and archived webcast will be accessible on SeaSpine's website. The company specializes in advanced spinal implants and orthobiologics, serving markets in the U.S. and approximately 30 countries.

Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the Canaccord Genuity 42nd Annual Global Growth Conference on August 10, 2022 beginning at 8:00 AM ET.

A live and archived webcast of the event will be available from the Investors section of the SeaSpine website at: www.seaspine.com.

About SeaSpine

SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine’s complete procedural solutions feature its market-leading FLASH™ Navigation, a system designed to improve accuracy of screw placement and provide a cost-effective, rapid, radiation-free solution to surgical navigation, and a comprehensive portfolio of spinal implants and orthobiologics to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures on the lumbar, thoracic and cervical spine. With product development expertise in advanced optics, software, orthobiologic sciences and spinal implants, SeaSpine can offer its surgeon customers a complete solution to meet their patients’ evolving clinical needs. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.


Investor Relations Contact
Leigh Salvo
ir@seaspine.com


FAQ

When is SeaSpine presenting at the Canaccord Genuity Conference?

SeaSpine will present at the Canaccord Genuity 42nd Annual Global Growth Conference on August 10, 2022, at 8:00 AM ET.

Where can I watch SeaSpine's conference presentation?

The presentation can be viewed live and archived on SeaSpine's website in the Investors section.

What products does SeaSpine focus on?

SeaSpine specializes in surgical solutions for spinal disorders, including the FLASH™ Navigation system and a comprehensive range of spinal implants and orthobiologics.

What is the stock symbol for SeaSpine?

The stock symbol for SeaSpine is SPNE, listed on NASDAQ.

In how many countries does SeaSpine market its products?

SeaSpine markets its products in the United States and approximately 30 other countries worldwide.

SPNE

NASDAQ:SPNE

SPNE Rankings

SPNE Latest News

SPNE Stock Data

360.18M
33.85M
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Carlsbad